Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,855,533
-
Total 13F shares
-
15,267,054
-
Share change
-
-175,733
-
Total reported value
-
$259,080,425
-
Price per share
-
$16.97
-
Number of holders
-
60
-
Value change
-
-$2,982,915
-
Number of sells
-
2
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2013
As of 31 Dec 2013,
PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,267,054 shares.
The largest 10 holders included
BROOKSIDE CAPITAL MANAGEMENT LLC, CREDIT SUISSE AG/, FMR LLC, WELLINGTON MANAGEMENT CO LLP, JENNISON ASSOCIATES LLC, RA CAPITAL MANAGEMENT, LLC, Novo A/S, ADAGE CAPITAL PARTNERS GP LLC, BlackRock Fund Advisors, and DEERFIELD MANAGEMENT CO.
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.